DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
04.09.2020 14:45:00
|
Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming virtual investor conferences:
- Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 4:20pm (EST).
- Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 at 11:20am (EST).
- Quentin Blackford, Chief Operating Officer and Chief Financial Officer, will present on behalf of the company at the Morgan Stanley 18th Annual Healthcare Conference on Tuesday, September 15, 2020 at 11:00am (EST).
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200904005138/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
06.05.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 beendet die Sitzung mit Verlusten (finanzen.at) | |
06.05.25 |
Schwacher Wochentag in New York: So bewegt sich der NASDAQ 100 nachmittags (finanzen.at) | |
06.05.25 |
Handel in New York: NASDAQ 100 in der Verlustzone (finanzen.at) | |
06.05.25 |
NASDAQ Composite Index-Papier DexCom-Aktie: So viel hätten Anleger mit einem Investment in DexCom von vor 5 Jahren verloren (finanzen.at) | |
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Gute Stimmung in New York: So steht der NASDAQ Composite am Nachmittag (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 71,72 | -0,44% |
|